Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.061 | 0.7 |